The More Things Change: Improvement Patents, Drug Modifications, and the FDA
Professor Dmitry Karshtedt , of George Washington University Law School, presented a working draft of her work The More Things Change: Improvement Patents, Drug Modifications, and the FDA. In this Article, he explains that the rules and institutions involved in determining the validity of patents on chemical inventions, certain features of drug regulation under the Federal Food, Drug, and Cosmetic Act, and unique market forces in the pharmaceutical sector combine to allow strategic product hopping.
From George Washington University Law School, “Dmitry Karshtedt's primary research interest is in patent law. His legal scholarship has been or will be published in the Vanderbilt Law Review, Washington University Law Review, and Iowa Law Review, and cited in three of the leading patent law casebooks and a casebook on intellectual property. Professor Karshtedt's academic work has won several awards, including the Samsung-Stanford Patent Prize and the scholarship grant for judicial clerks sponsored by the University of Houston Law Center Institute for Intellectual Property and Information Law."
FIU Law, FIU Law Faculty Workshop Series, Professor Dmitry Karshtedt, patents, drug, FDA, pharmaceutical industry, marketing
Karshtedt, Dmitry, "The More Things Change: Improvement Patents, Drug Modifications, and the FDA" (2018). Faculty Workshops.